360
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

History of Respiratory Events Prior to a First COPD Diagnosis and Future Exacerbations: A Longitudinal Observational Cohort Database Study in Japan

ORCID Icon, , , , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 247-258 | Received 09 Sep 2022, Accepted 24 Feb 2023, Published online: 07 Mar 2023

References

  • Global Initiative for Chronic Obstructive Lung Disease. 2022 GOLD report. Global strategy for the diagnosis, management and prevention of COPD; 2022. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed February 2, 2022.
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
  • Vogelmeier CF, Diesing J, Kossack N, Pignot M, Friedrich FW. COPD exacerbation history and impact on future exacerbations - 8-year retrospective observational database cohort study from Germany. Int J Chron Obstruct Pulmon Dis. 2021;16:2407–2417. doi:10.2147/COPD.S322036
  • Sethi S, Make BJ, Robinson SB, et al. Relationship of COPD exacerbation severity and frequency on risks for future events and economic burden in the medicare fee-for-service population. Int J Chron Obstruct Pulmon Dis. 2022;17:593–608. doi:10.2147/COPD.S350248
  • Whittaker H, Rubino A, Müllerová H, et al. Frequency and severity of exacerbations of COPD associated with future risk of exacerbations and mortality: a UK routine health care data study. Int J Chron Obstruct Pulmon Dis. 2022, ;17:427–437. doi:10.2147/COPD.S346591
  • Rothnie KJ, Müllerová H, Smeeth L, Quint JK. Natural history of chronic obstructive pulmonary disease exacerbations in a general practice-based population with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(4):464–471. doi:10.1164/rccm.201710-2029OC
  • Yawn BP, Wollan P, Rank M. Exacerbations in the pre- and post-COPD diagnosis periods. Pragmat Obs Res. 2013;4:1–6. doi:10.2147/POR.S41778
  • Okyere DO, Bui DS, Washko GR, et al. Predictors of lung function trajectories in population-based studies: a systematic review. Respirology. 2021;26(10):938–959. doi:10.1111/resp.14142
  • Sandelowsky H, Ställberg B, Nager A, Hasselström J. The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections - A case finding study. BMC Fam Pract. 2011;12(1):122. doi:10.1186/1471-2296-12-122
  • Whittaker H, Nordon C, Rubino A et al. Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study. Thorax. 2022,Oct 31. ():Epub ahead of print. doi:10.1136/thorax-2022-219039
  • JMDC. JMDC claims database; 2022. Available from: https://www.jmdc.co.jp/en/jmdc-claims-database/. Accessed June 7, 2022.
  • Wakabayashi Y, Eitoku M, Suganuma N. Characterization and selection of Japanese electronic health record databases used as data sources for non-interventional observational studies. BMC Med Inform Decis Mak. 2021;21(1):167. doi:10.1186/s12911-021-01526-6
  • Makita H, Suzuki M, Konno S, et al. Unique mortality profile in Japanese patients with COPD: an analysis from the Hokkaido COPD cohort study. Int J Chron Obstruct Pulmon Dis. 2020;15:2081–2090. doi:10.2147/COPD.S264437
  • Haruna A, Muro S, Nakano Y, et al. CT scan findings of emphysema predict mortality in COPD. Chest. 2010;138(3):635–640. doi:10.1378/chest.09-2836
  • Ono M, Kobayashi S, Hanagama M, et al. Clinical characteristics of Japanese patients with chronic obstructive pulmonary disease (COPD) with comorbid interstitial lung abnormalities: a cross-sectional study. PLoS One. 2020;15:e0239764. doi:10.1371/journal.pone.0239764
  • Hashimoto S, Sorimachi R, Jinnai T, Ichinose M. Asthma and chronic obstructive pulmonary disease overlap according to the Japanese respiratory society diagnostic criteria: the prospective, observational ACO Japan cohort study. Adv Ther. 2021;38(2):1168–1184. doi:10.1007/s12325-020-01573-x
  • Horinouchi H, Kusumoto M, Yatabe Y, Aokage K, Watanabe S-I, Ishikura S. Lung cancer in Japan. J Thorac Oncol. 2022;17(3):353–361. doi:10.1016/j.jtho.2021.11.020
  • The International Agency for Research on Cancer. GLOBOCAN 2020: Japan factsheet; 2020. Available from: https://gco.iarc.fr/today/data/factsheets/populations/392-japan-fact-sheets.pdf. Accessed May 11, 2022.
  • Masuda S, Omori H, Onoue A, et al. Comorbidities according to airflow limitation severity: data from comprehensive health examination in Japan. Environ Health Prev Med. 2017;22(1):13. doi:10.1186/s12199-017-0620-0
  • Nishida Y, Takahashi Y, Tezuka K, et al. A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2017;12:2363–2371. doi:10.2147/COPD.S138103
  • Hashimoto N, Matsuzaki A, Okada Y, et al. Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients. BMC Pulm Med. 2014;14:14. doi:10.1186/1471-2466-14-14
  • Ishii T, Nishimura M, Akimoto A, James MH, Jones P. Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries. Int J Chron Obstruct Pulmon Dis. 2018;13:3459–3471. doi:10.2147/COPD.S165187
  • Lange P, Ahmed E, Lahmar ZM, Martinez JF, Bourdin A. Natural history and mechanisms of COPD. Respirology. 2021;26(4):298–321. doi:10.1111/resp.14007
  • Tashiro H, Kurihara Y, Takahashi K, et al. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease. BMC Pulm Med. 2020;20(1):318. doi:10.1186/s12890-020-01362-w